Gut-derived peptide hormone receptor expression in the developing mouse hypothalamus

Author:

Cantacorps LídiaORCID,Coull Bethany M.,Falck Joanne,Ritter Katrin,Lippert Rachel N.ORCID

Abstract

Objective In adult organisms, a number of receptors have been identified which modulate metabolic processes related to peptides derived from the intestinal tract. These receptors play significant roles in glucose homeostasis, food intake and energy balance. Here we assess these classical metabolic receptors and their expression as well as their potential role in early development of hypothalamic neuronal circuits. Methods Chow-fed C57BL6/N female mice were mated and hypothalamic tissue was collected from offspring across postnatal development (postnatal day 7–21). Subsequent qPCR and Western Blot analyses were used to determine mRNA and protein changes in gut-derived peptide hormone receptors. Correlations to body weight, blood glucose and circulating leptin levels were analyzed. Results We describe the gene expression and dynamic protein regulation of key gut-derived peptide hormone receptors in the early postnatal period of the mouse brain. Specifically, we show changes to Gastric inhibitory polypeptide receptor (GIPR), glucagon-like peptide 1 receptor (GLP1R), and cholecystokinin receptor 2 (CCK2R) in the developing hypothalamus. The changes to GIPR and InsR seem to be strongly negatively correlated with body weight. Conclusions This comprehensive analysis underscores the need to understand the roles of maternal-derived circulating gut hormones and their direct effect on offspring brain development.

Funder

German Center for Diabetes Research

Deutsche Forschungsgemeinschaft

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism;F.M. Gribble;Nat Rev Endocrinol,2019

2. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1;D.J. Drucker;Cell Metab,2018

3. Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease;L.L. Baggio;Mol Metab,2021

4. Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models;E.A. Killion;Sci Transl Med,2018

5. A GLP-1/glucagon/CCK-2 receptors tri-agonist provides new therapy for obesity and diabetes;S. Zhao;Br J Pharmacol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3